CN Stock MarketDetailed Quotes

002932 Wuhan Easy Diagnosis Biomedicine

23.38 -0.28-1.18%
Market Closed 12/08 15:00 CST

About Wuhan Easy Diagnosis Biomedicine Company

The company was founded in 2008 and specializes in providing in vitro diagnostic reagents and supporting instrument products and integrated emergency and critical illness treatment. Currently, the company's main business has covered nearly 5,000 medical institutions in 30 provinces, municipalities directly under the Central Government and autonomous regions across the country, while also achieving a sales layout in various regions such as Asia, the European Union, and South America. In the fight against the COVID-19 epidemic, Mingde Biotech urgently developed a COVID-19 nucleic acid test kit and obtained a registration certificate, becoming a representative IVD enterprise in the affected area. At the same time, Mingde's COVID-19 nucleic acid reagents, antibody detection reagents, and blood gas analyzers have also obtained CE approval from the European Union and are eligible to be sold abroad. The company is mainly engaged in R&D, production, sales and service of in vitro diagnostic reagents and diagnostic instruments, and is committed to becoming a leading enterprise providing innovative and leading medical service products to medical institutions. The company's main products and services cover three areas: in vitro diagnostic reagents and instruments, emergency and critical illness informatization solutions, and third-party medical testing services. In addition, the company has other businesses such as selling a small number of proxy products and selling mobile square cabin PCR laboratories. Corporate honors: China's top 100 influential pharmaceutical companies, the top ten POCT brands recognized by the inspectors, etc., the outstanding enterprises in innovation and development in 2017, and the second batch of invisible champions in key industrial segments in Hubei Province.

Company Profile

Short Name-A明德生物
Company NameWuhan Easy Diagnosis Biomedicine Co.,Ltd.
Listing Date07/10/2018
Issue Price20.45
Shares Offered16.65M share
Listed ExchangeSZ Stock Exchange
Legal RepresentativeLili Chen
General ManagerLili Chen
SecretaryRui Wang
Accounting FirmLixin Certified Public Accountants (Special General Partnership)
Securities RepresentativeBo Xu
Legal CounselBeijing Dacheng Law Firm
Office AddressRoom 1, 1st Floor, Building 22, Wuhan Optics Valley International Biomedical Enterprise Accelerator Phase 1.2, No. 388, Gaoxin 2nd Road, Donghu New Technology Development Zone, Wuhan
Zip Code430075
Registered AddressNo. 388, Gaoxin 2nd Road, Donghu New Technology Development Zone, Wuhan City, Hubei Province, 1st Floor (3) Plant No. 3, Building 25, Wuhan Optics Valley International Biomedical Enterprise Accelerator Phase 3.1
Business License420100000053229
BusinessLicensed projects: Food production; beverage production; food management; Internet food sales; Internet hospital services based on physical hospitals (projects subject to approval by law, business activities can only be carried out after approval by relevant departments; specific business projects are subject to approval documents or licenses from relevant departments) General projects: production, development, sales and leasing of Class I, Class II and Class III medical devices (operating with a valid license); sales of general laboratory reagents (excluding hazardous chemicals and chemicals that are easy to manufacture); sales and after-sales of medical device management software Services; technology development, technical consulting, technology promotion, technology transfer of diagnostic technology and medical technology; production and wholesale and retail of analytical instruments and reagents in the agricultural, environmental and food fields; development, production and wholesale and retail of antigen antibody products, calibration products and quality control products; component manufacturing and wholesale and retail of instruments; computer software technology development, technology transfer, technical consulting and technical services; health consulting (excluding medical treatment); plastic products, communication equipment (excluding specialization), communication equipment (not included Radio transmitting equipment), power supply equipment, electronic products (excluding electronic publications), sensors, office supplies, electrical signal equipment, chemical reagents (excluding hazardous chemicals, monitoring chemicals, fireworks, explosives for civil use, chemicals prone to drug production), laboratory equipment, clinical testing analytical instruments and mechanical and electrical products, laboratory reagents, biological bactericides, biotechnology testing instruments and consumables, hardware, and daily necessities; import and export of goods, technology import and export, agency import and export (excluding goods or technology prohibited or restricted by the country); construction, laboratory engineering Intelligent engineering, steel structure engineering construction; laboratory equipment, wiring, and pipeline installation engineering (excluding pressure piping); construction of mechanical and electrical construction projects for construction of prefabricated buildings and building decoration projects; information system integration services; network equipment sales; hospital management; remote health management services; non-residential real estate leasing; housing leasing (except for projects subject to approval by law, independently carry out business activities with a business license in accordance with law)

Company Executives

  • Name
  • Position
  • Salary
  • Lili Chen
  • Chairman,Director,GM,Member of the Remuneration and Assessment Committee,Member of the Strategy Committee
  • --
  • Ying Wang
  • Vice Chairman,Director,Deputy GM,Nomination Committee Members,Member of the Strategy Committee
  • --
  • Jianfei Wang
  • Director
  • --
  • Zhenlu Zhang
  • Director,Member of the Strategy Committee
  • 120.00K
  • Xianwang Shi
  • Independent Director,Audit Committee Member,Nomination Committee Members
  • 9.50K
  • Jincheng Xie
  • Independent Director,Member of the Remuneration and Assessment Committee,Nomination Committee Members,Audit Committee Member
  • 50.00K
  • Rui Wang
  • Company Secretary,Deputy GM
  • --
  • Bo Xu
  • Securities Affairs Representative
  • --
  • Hanling Yang
  • Chairman of the Supervisory Board,Employee Representative Supervisor
  • 838.50K
  • Jinbo Chao
  • Supervisor
  • 740.70K
  • Youwen Zhao
  • Supervisor
  • 228.10K
  • Guohui Zhou
  • Head of finance
  • 839.60K
  • Ting Tang
  • Head of the internal audit department
  • --
  • Yi Quan
  • Audit Committee Member,Member of the Remuneration and Assessment Committee
  • 50.00K